Skip to main content
VCbacked
Log inGet Started

Interius BioTherapeutics

Philadelphia, United States

Interius BioTherapeutics is a biopharmaceutical company that develops in vivo cell-specific gene medicines to treat B cell lymphomas.

$51.4M raised
Jun 2024
Series B
BiopharmaBiotechnologyHealth CareTherapeutics

Top Investors

RA Capital ManagementCormorant Asset ManagementLongwood FundAgent CapitalUniversity of Pennsylvania

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Interius BioTherapeutics

How much funding has Interius BioTherapeutics raised?
Interius BioTherapeutics has raised $51.4M in total funding. The most recent round was Series B. The last funding was announced in June 2024.
Who are Interius BioTherapeutics's investors?
Interius BioTherapeutics's investors include RA Capital Management, Cormorant Asset Management, Longwood Fund, Agent Capital, University of Pennsylvania.
Where is Interius BioTherapeutics headquartered?
Interius BioTherapeutics is headquartered in Philadelphia, United States.
What does Interius BioTherapeutics do?
Interius BioTherapeutics is a biopharmaceutical company that develops in vivo cell-specific gene medicines to treat B cell lymphomas.
What stage is Interius BioTherapeutics at?
Interius BioTherapeutics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Interius BioTherapeutics — Funding & Investors." VCBacked, June 3, 2024, https://www.vcbacked.co/company/interius-biotherapeutics. Accessed June 4, 2026.
APA
VCBacked. (2024). Interius BioTherapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/interius-biotherapeutics
Wikipedia (cite web)
{{cite web |title=Interius BioTherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/interius-biotherapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biopharma

View all
ParcelBio
San Francisco$13.2M
Modicus Prime
Austin
Latus Bio
Philadelphia
Ocugen
Malvern
Ember LifeSciences
Los Angeles$16.5M
ClearNote Health
San Diego